Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma

Clinical trial NCT00088205 · COMPLETED

Trial details

NCT number: NCT00088205
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle-Cell Lymphoma

Start date: 2004-03-01
Primary completion: 2008-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.